Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6QAH

ERK2 mini-fragment binding

Summary for 6QAH
Entry DOI10.2210/pdb6qah/pdb
DescriptorMitogen-activated protein kinase 1, SULFATE ION, 1-azanylpropylideneazanium, ... (4 entities in total)
Functional Keywordsser/thr kinase, signal transduction, atp binding, signaling protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight42794.22
Authors
O'Reilly, M.,Cleasby, A.,Davies, T.G.,Hall, R.,Ludlow, F.,Murray, C.W.,Tisi, D.,Jhoti, H. (deposition date: 2018-12-19, release date: 2019-06-26, Last modification date: 2024-11-06)
Primary citationO'Reilly, M.,Cleasby, A.,Davies, T.G.,Hall, R.J.,Ludlow, R.F.,Murray, C.W.,Tisi, D.,Jhoti, H.
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.
Drug Discov Today, 24:1081-1086, 2019
Cited by
PubMed Abstract: We present a novel crystallographic screening methodology (MiniFrags) that employs high-concentration aqueous soaks with a chemically diverse and ultra-low-molecular-weight library (heavy atom count 5-7) to identify ligand-binding hot and warm spots on proteins. We propose that MiniFrag screening represents a highly effective method for guiding optimisation of fragment-derived lead compounds or chemical tools and that the high screening hit rates reflect enhanced sampling of chemical space.
PubMed: 30878562
DOI: 10.1016/j.drudis.2019.03.009
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.58 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon